Biomarker-Driven Pharmacokinetics and Efficacy of Polymyxin B in Critically Ill Patients with XDR-GN Pneumonia
<b>Background:</b> Achieving pharmacokinetic/pharmacodynamic (PK/PD) targets is critical for improving treatment success, particularly in critically ill patients. This study investigates the role of inflammatory biomarkers and their influence on the PK/PD characteristics of polymyxin B (...
Saved in:
| Main Authors: | Wei Zuo, Qianlin Wang, Longxiang Su, Jiaxin Yu, Hongwei Fan, Qiang Fu, Yun Long, Bo Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/4/586 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monte Carlo simulation to optimize polymyxin B dosing regimens for the treatment of Gram-negative bacteremia
by: Yingying Yu, et al.
Published: (2025-02-01) -
Local and systemic cytokine profiles in children with pneumonia-associated lung consolidation
by: Jilei Lin, et al.
Published: (2025-05-01) -
Population pharmacokinetics of polymyxin B in critically ill patients with carbapenem-resistant organisms infections: insights from steady-state trough and peak plasma concentration
by: Jun Yang, et al.
Published: (2025-03-01) -
The predictive value of MUC5AC levels in the sputum of children with Mycoplasma pneumoniae pneumonia treated with fiberbronchoscopy
by: Xiao-qing Jian, et al.
Published: (2025-08-01) -
Analysis of cytokine levels, cytological findings, and MP‐DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia
by: Fang Deng, et al.
Published: (2023-05-01)